HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Cong Selected Research

gan-fu-kang

9/2013Protective effect of the herbal medicine Gan‑fu‑kang against carbon tetrachloride‑induced liver fibrosis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Cong Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 01/2020
4Obesity
01/2014 - 05/2007
3Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
2Breast Neoplasms (Breast Cancer)
10/2021 - 01/2011
1Asthma (Bronchial Asthma)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Cerebral Infarction
01/2022
1Cognitive Dysfunction
10/2021
1Neurobehavioral Manifestations
10/2021
1Neuroinflammatory Diseases
10/2021
1Atherosclerosis
07/2021
1COVID-19
05/2021
1Inflammation (Inflammations)
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2019
1Carcinogenesis
01/2018
1Papillary Thyroid Cancer
01/2018
1Brain Injuries (Brain Injury)
01/2017
1Infections
10/2015
1Hypersensitivity (Allergy)
10/2015
1Hypoxia (Hypoxemia)
08/2015
1Atrial Fibrillation
08/2015
1Heart Valve Diseases (Valvular Heart Disease)
08/2015
1Overweight
01/2014
1Pain (Aches)
12/2013
1Cough
12/2013
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2013
1Body Weight (Weight, Body)
09/2013
1Endometrial Neoplasms (Endometrial Cancer)
09/2007
1Type 2 Diabetes Mellitus (MODY)
05/2007
1Insulin Resistance
05/2007

Drug/Important Bio-Agent (IBA)

4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2020
3Long Noncoding RNAIBA
01/2022 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2007
3AdiponectinIBA
01/2011 - 05/2007
2Messenger RNA (mRNA)IBA
01/2022 - 01/2020
2Pharmaceutical PreparationsIBA
01/2022 - 10/2021
2Circular RNAIBA
01/2020 - 01/2018
2CateninsIBA
01/2018 - 09/2013
2EnzymesIBA
01/2014 - 09/2013
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
01/2022
1PolymersIBA
01/2022
1Cell-Penetrating PeptidesIBA
01/2022
1SteroidsIBA
01/2022
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
10/2021
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
10/2021
1Angiopoietin-2IBA
10/2021
1TOR Serine-Threonine KinasesIBA
10/2021
1BiglycanIBA
10/2021
1Antimalarials (Antimalarial Agents)IBA
10/2021
1ArtemetherFDA Link
10/2021
1tau Proteins (tau Protein)IBA
10/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1Food Additives (Food Additive)IBA
07/2021
1Uric Acid (Urate)IBA
05/2021
1CreatinineIBA
05/2021
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1XIST non-coding RNAIBA
01/2019
1Interleukin-4 (Interleukin 4)IBA
10/2015
1salicylhydroxamic acid (SHAM)IBA
08/2015
1CalpainIBA
08/2015
1CalcineurinIBA
08/2015
1LipidsIBA
01/2014
1gan-fu-kangIBA
09/2013
1Tissue Inhibitor of Metalloproteinase-1IBA
09/2013
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2013
1Therapeutic UsesIBA
09/2013
1CollagenIBA
09/2013
1Carbon Tetrachloride (Tetrachloromethane)IBA
09/2013
1CarbonIBA
09/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2011
1CarbohydratesIBA
05/2007

Therapy/Procedure

2Therapeutics
01/2022 - 01/2020
1Oral Administration
10/2021
1Intraperitoneal Injections
01/2021
1Transplantation
01/2017
1Ligation
08/2015
1Analgesia
12/2013
1Subcutaneous Injections
09/2013